Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

BillionToOne (BLLN) Q3 2026 Earnings Call Transcript

@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo

We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.

Also reported by 1 other outlet

Read the original at nasdaq.com →

More in Finance & Markets

Amgen vs. Pfizer: Which Healthcare Stock Is a Better Buy for 2027?

Amgen's growth engine and Pfizer's value appeal pull in opposite directions, and the valuation gap between them is wider than many expect.

  • Amgen focuses on specialized biological medicines, particularly in oncology and rare diseases.
  • Pfizer operates globally with a vast distribution network and pharmacy chains.
  • Amgen shows higher revenue growth and lower debt-to-equity ratio compared to Pfizer.

More from Thursday 5 November →